These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8171631)

  • 1. Effect of anti-interleukin-2 receptor antibody treatment on recurrent autoimmune insulitis in the BB rat.
    Woehrle M; Pullmann J; Stuenkel KG; Bretzel RG; Federlin K
    Transplant Proc; 1994 Apr; 26(2):734-5. PubMed ID: 8171631
    [No Abstract]   [Full Text] [Related]  

  • 2. Temporary anti-CD-25 treatment results in tolerance development in syngeneically grafted autoimmune diabetic recipients.
    Hahn HJ; Kuttler B; Dunger A; Lucke S; Volk HD; Diamantstein T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):741-2. PubMed ID: 1990673
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of temporary IL-2 receptor MAB therapy on islet allograft in autoimmune diabetes.
    Hahn HJ; Kuttler B; Lucke S; Dunger A; Besch W; Volk HD; Diamankstein T
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2711-3. PubMed ID: 2495678
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin 2 receptor-targeted therapy in islet transplantation research.
    Hahn HJ; Kuttler B; Volk HD; Lucke S; Diamantstein T
    Horm Metab Res Suppl; 1990; 25():177-80. PubMed ID: 2088963
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of MHC compatibility in recurrence of autoimmune type I diabetes mellitus: comparison of the immune response of BB/W rats to pancreatic islet and heart allografts.
    Tezuka K
    Bull Osaka Med Coll; 1990 Nov; 36(1-2):57-69. PubMed ID: 2135645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathymic inoculation of islets at birth prevents autoimmune diabetes and pancreatic insulitis in the BB rat.
    Posselt AM; Barker CF; Friedman AL; Koeberlein B; Tomaszewski JE; Naji A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):301-2. PubMed ID: 8438310
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of recurrent autoimmune islet transplant destruction by simultaneous kidney transplantation.
    Bartlett ST; Dirden B; Schweitzer EJ; Sheffield C; Hadley GA
    Transplant Proc; 1994 Apr; 26(2):737. PubMed ID: 8171633
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrathymic islet allografts prevent hyperglycemia and autoimmune beta-cell destruction in BB rats following transplantation in the prediabetic period.
    Brayman KL; Nakai I; Field J; Lloveras JJ; Farney A; Najarian JS; Sutherland DE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):284-5. PubMed ID: 8438301
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of islet graft destruction in diabetic mice and rats by temporary anti-IL-2 receptor therapy: comparison of different strategies.
    Kuttler B; Mathieu C; Bulfone-Paus S; Bouillon R; Diamantstein T; Hahn HJ
    Transplant Proc; 1998 Dec; 30(8):4140-2. PubMed ID: 9865327
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of MHC-incompatible intraportal islet and vascularized whole-pancreas transplantation in the prehyperglycemic phase of autoimmune diabetes.
    Nakai I; Oda T; Mitsuo M; Shimizu Y; Arakawa K; Oka T; Sutherland DE; Brayman KL
    Transplant Proc; 1994 Apr; 26(2):738. PubMed ID: 8171634
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies.
    Kuttler B; Rösing K; Lehmann M; Brock J; Hahn HJ
    J Mol Med (Berl); 1999 Jan; 77(1):226-9. PubMed ID: 9930969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 2 receptor targeted immunotherapy in the prevention of autoimmune beta-cell destruction as observed in diabetic BB/OK rats grafted with BB/OK rat islets.
    Hahn HJ; Kauert C; Dunger A; Kuttler B; Diamantstein T
    Autoimmunity; 1989; 5(1-2):139-42. PubMed ID: 2519014
    [No Abstract]   [Full Text] [Related]  

  • 13. Recurrence of diabetes after islet transplantation in the BB rat.
    Woehrle M; Pullmann J; Bretzel RG; Federlin K
    Transplant Proc; 1992 Jun; 24(3):999. PubMed ID: 1604707
    [No Abstract]   [Full Text] [Related]  

  • 14. Syngeneic islets transplanted into the thymus of newborn mice prevent diabetes and reduce insulitis in the NOD mouse.
    Nomura Y; Mullen Y; Stein E
    Transplant Proc; 1993 Feb; 25(1 Pt 2):963-4. PubMed ID: 8442281
    [No Abstract]   [Full Text] [Related]  

  • 15. Islet xenografting in autoimmune diabetes.
    Gill RG; Coulombe M
    Transplant Proc; 1994 Jun; 26(3):1140. PubMed ID: 7913256
    [No Abstract]   [Full Text] [Related]  

  • 16. Extended survival of MHC-identical allogeneic islet grafts in diabetic BB rats--the effect of an interleukin 2 receptor-targeted immunotherapy.
    Hahn HJ; Kuttler B; Klöting I; Dunger A; Besch W; Diamantstein T
    Transplantation; 1992 Sep; 54(3):555-8. PubMed ID: 1412738
    [No Abstract]   [Full Text] [Related]  

  • 17. BB islets transplanted ectopically to the kidney or thymus prevent progression to diabetes from autoimmunity in BB rats.
    Shinagawa Y; Brayman K; Field J; Farney A; Najarian J; Sutherland D
    Transplant Proc; 1994 Apr; 26(2):739. PubMed ID: 8171635
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose dependence of bacillus Calmette-Guerin on the prevention of autoimmune diabetes in syngeneic islet transplantation.
    Lakey JR; Singh B; Warnock GL; Elliott JF; Rajotte RV
    Transplant Proc; 1995 Dec; 27(6):3413. PubMed ID: 8540025
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes.
    Hu C; Deng S; Wong FS; Wen L
    Ann N Y Acad Sci; 2008 Dec; 1150():217-9. PubMed ID: 19120299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 receptor-targeted immune therapy.
    Diamantstein T; Hahn HJ
    Immunol Ser; 1993; 59():295-318. PubMed ID: 8461395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.